A record for the reading desk
Liraglutide
Aliases: Saxenda
The recorded fields, their references, and a question worth keeping.
- Status
- Approved product
- Evidence label
- Randomized evidence
- Index topics
- Metabolism
- Status as of
Record / 01
Recorded fields
- Mechanism
- Activates the GLP-1 receptor.
- Evidence
- Randomized trials.
- Limitations
- Check other products separately.
- Safety
- The label warns about severe gastrointestinal reactions.
- Route context
- Subcutaneous injection.
- Approval scope
- Saxenda: weight management for eligible patients.
Reasoning / 02
A note for your reading
Before interpreting a dramatic shape in a chart, read the scale that gives the shape its meaning. A cropped axis could make a small difference occupy much of the display. Uneven spacing could make equal movements on the page represent unequal changes in value. Neither feature settles whether the underlying comparison is useful. The next step is to recover the labeled values and describe their relationship without relying on the picture's visual force. Then return to the chart and decide whether its presentation helps communicate that relationship clearly.
Keep asking / 03
Three questions to carry forward
- What values do the axis labels assign to the distances shown?
- Would the same values appear less dramatic under another clearly labeled scale?
- Can I describe the comparison accurately without borrowing emphasis from the graphic?
Trace the record / 04
References
- SAXENDA
NLM · Checked